Recent rapid biotechnological breakthroughs have led to the identification of complex and
unique molecular features that drive malignancies. Precision medicine has exploited next …

Despite tremendous gains in the molecular understanding of exocrine pancreatic cancer,
the prognosis for this disease remains very poor, largely because of delayed disease …

Highlights•This ESMO Guideline provides key recommendations on the role of PROMs
during the care of patients with cancer.•It covers the use of PROMs in patients with cancer …

PURPOSE To provide evidence-based guidance on the clinical management of cancer
cachexia in adult patients with advanced cancer. METHODS A systematic review of the …

Epithelial ovarian cancer generally presents at an advanced stage and is the most common
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …

Objective To evaluate effects of remote monitoring of adjuvant chemotherapy related side
effects via the Advanced Symptom Management System (ASyMS) on symptom burden …

PURPOSE Electronic patient self-Reporting of Adverse-events: Patient Information and
aDvice (eRAPID) is an online eHealth system for patients to self-report symptoms during …

Methods| The study was approved by the Memorial Sloan Kettering institutional review
board and written informed consent was obtained from participants. Consecutive patients …

Strategies that individualize the care of cancer patients receiving oral anticancer agents offer
opportunities to improve treatment adherence and patient care. However, the impact of …

Background In this paper, we report the findings of a realist synthesis that aimed to
understand how and in what circumstances patient reported outcome measures (PROMs) …